Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic cloning: concepts and practicalities.

A Colman1, A Kind

  • 1PPL Therapeutics, Roslin, Edinburgh, UK. acolman@ppl-therapeutics.com

Trends in Biotechnology
|April 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diversifying Recruitment Registries: Considering Neighborhood Health Metrics.

The journal of prevention of Alzheimer's disease·2022
Same author

First Report of Stigmina palmivora Causing Leaf Spots on Phoenix roebelenii in Brazil.

Plant disease·2019
Same author

First Report of Downy Mildew (Hyaloperonospora lunariae) on White Mustard (Sinapis alba) in Brazil.

Plant disease·2019
Same author

Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.

Journal of viral hepatitis·2018
Same author

Sci-Thurs PM: Delivery-05: One year of learning from incidents.

Medical physics·2017
Same author

A porcine model of osteosarcoma.

Oncogenesis·2016
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
See all related articles

Embryonic stem (ES) cells offer potential for tissue repair. Genetically identical, customized ES cell lines for patients are now a realistic possibility, advancing regenerative medicine.

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Tissue Engineering

Background:

  • The use of embryonic stem (ES) cells for tissue repair has been explored for two decades.
  • Recent advancements include somatic nuclear transfer and human ES cell derivation.
  • The potential for patient-specific, genetically identical ES cell lines is a significant development.

Purpose of the Study:

  • To examine the historical background of embryonic stem cell applications in tissue repair.
  • To explore the future prospects of patient-specific ES cell technologies.
  • To review recent breakthroughs in ES cell derivation and nuclear transfer.

Main Methods:

  • Review of existing literature on stem cell research.
  • Analysis of recent breakthroughs in somatic nuclear transfer.

Related Experiment Videos

  • Examination of human embryonic stem cell derivation techniques.

    • Main Results:

    • The concept of using ES cells for tissue repair is well-established.
    • Somatic nuclear transfer and human ES cell derivation have accelerated research.
    • Patient-specific ES cell lines are becoming a tangible reality.

    Conclusions:

    • Embryonic stem cells hold significant promise for regenerative medicine.
    • Technological advancements are paving the way for personalized stem cell therapies.
    • The future of tissue repair is increasingly reliant on customized stem cell solutions.